GLOBAL BLOOD THERAPEUTICS IN (GBT) Stock News
NASDAQ:GBT - Nasdaq - US37890U1088 - Common Stock - Currency: USD
GBT Latest News, Press Relases and Analysis
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates MNRL, STOR, GBT, IRBT
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
INVESTIGATION ALERT: Halper Sadeh LLC Investigates FBMS, GBT, MVBF
/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
GBT Supports the Sickle Cell Disease Treatment Centers Act of 2022
Congress Moves to Expand Funding for National Network of Specialized Treatment Centers and Community Organizations for Sickle Cell Disease Patients...
Something Unusual Is Happening Right Now With Biotech Stocks Like Catalyst, Vertex, Neurocrine And BioMarin
The market is struggling, yet biotech stocks are acting like it's good times again. Here's why.
Global Blood Therapeutics's Return On Capital Employed Overview
Benzinga Pro data, Global Blood Therapeutics (NASDAQ:GBT) reported Q2 sales of $71.55 million. Earnings fell to a loss of $82.47 million, resulting in a 1.29% decrease from last quarter.
SHAREHOLDER NOTICE: Halper Sadeh LLP Investigates FTAI, SBTX, CVET, GBT
/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds SBTX, CVET, GBT, and MSTR Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Global Blood Therapeutics's Return On Capital Employed Overview
Global Blood Therapeutics (NASDAQ:GBT) brought in sales totaling $71.55 million during Q2 according to data provided by Benzinga Pro. However, earnings decreased 1.29%, resulting in a loss of $82.47 million.
SHAREHOLDER ALERT: Weiss Law Reminds LTRY, MSTR, GBT, and PFHD Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
10 Biotech Stocks Are Up 40% Or More This Year, Including Karuna, Axsome And Others
These names are benefitting from M&A, clinical data and promising regulatory actions.
SHAREHOLDER ALERT: Weiss Law Reminds CYBE, GBT, PFHD, and BBQ Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Pfizer Bidding War With J&J Preceded Global Blood Therapeutics Deal
Blistering-Hot Biotech Shopping Spree Continues: Alcon To Buy Aerie For $770 Million
The biopharma buying spree continued Tuesday with glaucoma drugs maker Aerie.
Pfizer Inks $5.4 Billion Deal To Acquire Global Blood Therapeutics
The deal adds to Pfizer's efforts to tackle sickle cell disease.
Mentions: PFE
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates AAWW, GBT, CYBE, AVLR
/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SHAREHOLDER ALERT: Weiss Law Reminds AVLR, CYBE, GBT, and PFHD Shareholders About Its Ongoing Investigations
/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...
Stock Market Rally Rises On Inflation Data; Nvidia, Micron, Tesla, Disney In Focus: Weekly Review
The major indexes continued to advance, despite some key warnings.
SHAREHOLDER ALERT: Weiss Law Investigates Global Blood Therapeutics, Inc.
/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Global Blood...
Mentions: PFE
TBLT, RDBX: The Top 5 Short Squeeze Stocks to Watch This Week
Short squeeze stocks are still a hot topic this week and we're listing five of the shares investors will want to keep an eye on!
SHAREHOLDER INVESTIGATION NOTICE: Halper Sadeh LLP Investigates GBT, AVLR, CYBE
/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
GBT Stock Alert: Pfizer Is Officially Acquiring Global Blood Therapeutics
GBT stock is already rallying on takeover talk. Now that Pfizer has confirmed the buyout, Global Blood Therapeutics is red hot.
Mentions: PFE
